NCT07073547
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07073547
Title A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Research Site RECRUITING Duarte California 91010 United States Details
Research Site RECRUITING Denver Colorado 80218 United States Details
Research Site RECRUITING Tampa Florida 33612 United States Details
Research Site NOT_YET_RECRUITING Atlanta Georgia 30322 United States Details
Research Site RECRUITING St Louis Missouri 63110 United States Details
Research Site RECRUITING New York New York 10016 United States Details
Research Site RECRUITING Nashville Tennessee 37203 United States Details
Research Site NOT_YET_RECRUITING Dallas Texas 75235 United States Details
Research Site NOT_YET_RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field